HIF1A and breast cancer: Indeed, studies by Yang et al. showed that expression of the HIF-1α gene, a regulator of the hypoxic response, or a hypoxia meta-gene signature was associated with a poor outcome to endocrine treatment in ERα (+) breast cancer.